Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
Marquez, P
Although rare with semaglutide, serious hypersensitivity reactions have been reported and require emergency treatment
Understanding and following appropriate storage guidelines ensures that patients receive the full therapeutic benefit of the medication while minimizing the risk of using degraded or contaminated product
On days when appetite suppression is severe, use calorie-dense but nutrient-rich foods to meet minimums
NADH Dr Lapp recommends 10-20mg of NADH daily, which may take three to six months to work, with only a "subtle" response